Centessa Pharmaceuticals: Funding, Investors & Team (Sep 2026)
Centessa Pharmaceuticals is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. The company applies an asset-centric R&D model at scale to advance a portfolio of highly validated programs led by industry-leading teams. Each program is developed by a Centessa Subsidiary and supported by a centralized infrastructure and the Centessa management team.
Centessa Pharmaceuticals has raised $300M across 1 funding round on record, the most recent a Post-IPO Debt of $300M announced in Oct 2021.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Centessa Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Oct 2021.
Centessa Pharmaceuticals Funding Rounds
Centessa Pharmaceuticals Founders and Leadership Team
Contact details for the Centessa Pharmaceuticals team: 1 of 1 has an email address on file.
Start 14-day free trial →Centessa Pharmaceuticals Funding Compared to Other Biotechnology Startups
Centessa Pharmaceuticals' latest round of $300M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Centessa Pharmaceuticals in Biotechnology and Cambridge
Companies Similar to Centessa Pharmaceuticals
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Centessa Pharmaceuticals Funding FAQs
What does Centessa Pharmaceuticals do?
Centessa Pharmaceuticals is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. The company applies an asset-centric R&D model at scale to advance a portfolio of highly validated programs led by industry-leading teams. Each program is developed by a Centessa Subsidiary and supported by a centralized infrastructure and the Centessa management team.
How much funding has Centessa Pharmaceuticals raised?
Centessa Pharmaceuticals has raised $300M across 1 round on record. The most recent is a Post-IPO Debt of $300M announced in Oct 2021.
When did Centessa Pharmaceuticals last raise funding?
Centessa Pharmaceuticals' most recent funding round on record is a Post-IPO Debt of $300M, announced in Oct 2021.
Who is the CEO of Centessa Pharmaceuticals?
Saurabh Saha is listed as CEO at Centessa Pharmaceuticals.
Where is Centessa Pharmaceuticals headquartered?
Centessa Pharmaceuticals is based in Cambridge, Massachusetts, United States.
How many employees does Centessa Pharmaceuticals have?
Centessa Pharmaceuticals is in the 11-50 employee band.
How does Centessa Pharmaceuticals' funding compare to other Biotechnology startups?
Centessa Pharmaceuticals' latest round of $300M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Centessa Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Centessa Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.